<DOC>
	<DOCNO>NCT02643134</DOCNO>
	<brief_summary>The traditional stone row method comprise increase exercise , drink lot water , drug row stone stone row position . External physical vibration lithecbole ( EPVL ) non-invasive device active row stone , researcher hope test prospective clinical study evaluate effectiveness vitro physical vibration row stone extracorporeal shockwave lithotripsy ( ESWL ) treatment stone discharge , thereby improve ESWL stone clearance rate .</brief_summary>
	<brief_title>External Physical Vibration Lithecbole Versus Traditional Row Stone After Extracorporeal Shockwave Lithotripsy ( ESWL )</brief_title>
	<detailed_description>To evaluate efficacy safety external physical vibration lithecbole ( EPVL ) treatment ESWL treatment stone discharged，thereby improve extracorporeal shockwave lithotripsy ( ESWL ) stone clearance rate . Investigators multi-centers randomize control trial ( RCT ) ，and investigator plan perform study 10 hospitals，which First Affiliated Hospital Guangzhou Medical University China , Department Urology , The Second Affiliated Hospital Zhengzhou University China , Jiangsu Province Hospital , Hubei Province Hospital , Zhongshan Hospital , Tongji Hospital , Hubei provincial people 's Hospital , Guilin 181 Hospital，the People ' Hospital Huzhou，The People ' Hospital Shaoyang . Investigators plan begin study August 2015 end July 2016 . One hundred eighty patient ESWL postoperative residual stone enrol study . By simple random sampling technique , patient assign segment natural stone row group physical row stone group , compare two group patient stone clearance rate complication , Investigators hope test , improve stone clearance rate ESWL . Number : 180cases ( 90 case control group , 90 case EPVL group ) Grouping method : In trial , investigator use equilibrium randomization method generate random numerical code table , accord table , patient randomly assign different group . Evaluating indicator Stone-free rate 4 week ESWL . Incidence rate complication adverse reaction EPVL ( fever , hematuria , etc ) . Trial method : Examination ESWL : blood routine , urine routine , renal function ( Cre , BUN ) , coagulation function ; intravenous pyelography ( IVP ) CT ( radiolucent calculus ) . ESWL Record : duration , frequency , voltage , time . Method control group ( group1 ) : ESWL without EPVL ; Reexamined abdominal plain film ( KUB ) CT ( radiolucent calculus ) right ESWL ; After leave hospital ( without drug ) , patient follow measure bellow : 1. amount fluid intake 2000ml/d 2. increase physical activity 3. rest position uninjured side , patient low renal calyx calculus need invert body . Method EPVL group ( group2 ) : Start treatment EPVL : amount fluid intake 1000-2000ml , start treatment EPVL patent 's bladder filling ; Reexamined abdominal plain film ( KUB ) CT ( radiolucent calculus ) right EPVL ; Record : patient ' date , treatment procedure outcome ; After leave hospital ( without drug ) , patient follow measure bellow : 1. amount fluid intake 2000ml/d 2. increase physical activity 3. rest position uninjured side , patient low renal calyx calculus need invert body ; Follow timing : return hospital respectively 1,2 4 week EPVL . Follow project Laboratory testing : routine urinalysis ; Imaging examination : KUB kidney CT scan ( radiolucent calculus ) Complications adverse reaction . Data gathering Fill follow table data ; Radiological image ; IVP kidney CT scan ESWL ; Reexamined KUB ( radiopaque calculus ) CT ( radiolucent calculus ) right EPVL . If stone eliminate completely patient radiolucent calculus fourth week follow-up , investigator must provide kidney CT scan .</detailed_description>
	<mesh_term>Calculi</mesh_term>
	<mesh_term>Kidney Calculi</mesh_term>
	<mesh_term>Nephrolithiasis</mesh_term>
	<criteria>1 . Age 1865 year ; 2 . The diameter calculus less equal 15mm ; 3 . Renal upper ureteral calculus ; 4 . There 's urinary tract obstruction stone , stone n't cause complete urinary tract obstruction ; 5 . Stones fragment successfully single session ESWL , diameter fragment le 6mm ; 6 . Normal renal function , 1 . Could n't tolerate EPVL ; 2 . Urinary tract anomaly , stricture obstruction ; 3 . Calculus diverticulum ; 4 . Severe hydronephosis ; 5 . Combined acute urinary tract infection ; 6 . Coagulation abnormality ; 7 . Morbid obesity ( BMI &gt; 35kg/m2 ) ; 8 . Patients ureteral stent ; 9 . Stones n't fragment successfully , diameter least one fragment 6mm ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>ESWL</keyword>
	<keyword>EPVL</keyword>
	<keyword>PDI ( Percussion , Diuresis , Inversion )</keyword>
	<keyword>Randomized Controlled Trial ( RCT )</keyword>
</DOC>